Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cipla
Covington
Boehringer Ingelheim
Medtronic
Farmers Insurance
Harvard Business School
Johnson and Johnson
Argus Health
Express Scripts

Generated: February 20, 2018

DrugPatentWatch Database Preview

KARBINAL ER Drug Profile

« Back to Dashboard

When do Karbinal Er patents expire, and what generic alternatives are available?

Karbinal Er is a drug marketed by Tris Pharma Inc and is included in one NDA. There are two patents protecting this drug.

This drug has twenty-one patent family members in fourteen countries.

The generic ingredient in KARBINAL ER is carbinoxamine maleate. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.
Summary for KARBINAL ER
Drug patent expirations by year for KARBINAL ER
Pharmacology for KARBINAL ER

US Patents and Regulatory Information for KARBINAL ER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tris Pharma Inc KARBINAL ER carbinoxamine maleate SUSPENSION, EXTENDED RELEASE;ORAL 022556-001 Mar 28, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Tris Pharma Inc KARBINAL ER carbinoxamine maleate SUSPENSION, EXTENDED RELEASE;ORAL 022556-001 Mar 28, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for KARBINAL ER

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,202,537 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
8,597,684 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
9,549,989 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
8,747,902 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
8,883,217 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
9,675,703 Modified release formulations containing drug - ion exchange resin complexes ➤ Try a Free Trial
9,198,864 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
8,790,700 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
8,337,890 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
8,491,935 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for KARBINAL ER

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Chubb
Cantor Fitzgerald
Colorcon
Cerilliant
Fish and Richardson
Johnson and Johnson
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot